Cargando…
Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline
The 2021 World Health Organization (WHO) classification of CNS tumors incorporates molecular signatures with histology and has highlighted differences across pediatric vs adult-type CNS tumors. However, adolescent and young adults (AYA; aged 15–39), can suffer from tumors across this spectrum and is...
Autores principales: | Lim-Fat, Mary Jane, Macdonald, Maria, Lapointe, Sarah, Climans, Seth Andrew, Cacciotti, Chantel, Chahal, Manik, Perreault, Sebastien, Tsang, Derek S., Gao, Andrew, Yip, Stephen, Keith, Julia, Bennett, Julie, Ramaswamy, Vijay, Detsky, Jay, Tabori, Uri, Das, Sunit, Hawkins, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559579/ https://www.ncbi.nlm.nih.gov/pubmed/36249063 http://dx.doi.org/10.3389/fonc.2022.960509 |
Ejemplares similares
-
SURVEY OF CANADIAN NEURO-ONCOLOGY CLINICIANS ABOUT THE TREATMENT OF ADULT MEDULLOBLASTOMA
por: Cacciotti, Chantel, et al.
Publicado: (2023) -
ACQUIRED PTEN LOSS MAY MEDIATE DABRAFENIB AND TRAMETINIB RESISTANCE IN BRAF V600E–MUTATED EPITHELIOID GLIOBLASTOMA: A CASE REPORT
por: Ahmed, Abrar, et al.
Publicado: (2023) -
LGG-41. The clinical and molecular landscape of gliomas in adolescents and young adults
por: Bennett, Julie, et al.
Publicado: (2022) -
Pediatric central nervous system tumor survivor and caregiver experiences with multidisciplinary telehealth
por: Cacciotti, Chantel, et al.
Publicado: (2023) -
Adolescent and young adult glioma: systematic review of demographic, disease, and treatment influences on survival
por: Malhotra, Armaan K, et al.
Publicado: (2022)